Klemens Budde - Concepedia

Author

Klemens Budde

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Adelheid Wiemer-Kruel, B Banas, Budde, Budde K, Budde, K., Budde, Klemens, Caner Süsal, Daniel Abramowicz, Henrik Birn, K BUDDE

978

Publications

33.5K

Citations

H-Index

229

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Heidelberg University Medical University of Vienna Medizinische Hochschule Hannover

About

Klemens Budde is an author at Charité - Universitätsmedizin Berlin specializing in medicine, kidney transplant, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	135	8.5K
2	Health Sciences	8	8	378
3	Engineering	6	6	132
4	Natural Sciences	2	2	158
5	Language Studies	1	1	14

Klemens Budde

382

Publications

27K

Citations

H-Index

Page 1

	Year	Citations
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Hope Northrup, Darcy A. Krueger, Hope Northrup, Pediatric Neurology	2013	1.5K
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska, The Lancet Tuberous Sclerosis ComplexSporadic LymphangioleiomyomatosisPathologyPlacebo-controlled TrialScleroderma	2013	863
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection Duska Dragun, Dominik N. Müller, Jan Hinrich Bräsen, New England Journal of Medicine	2005	840
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference Darcy A. Krueger, Hope Northrup, Hope Northrup, Pediatric Neurology	2013	834
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations Hope Northrup, Mary E. Aronow, E. Martina Bebin, Pediatric Neurology	2021	644
Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus Flavio Vincenti, S. Friman, Ernst‐Heinrich Scheuermann, American Journal of Transplantation	2007	609
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease Gerd Walz, Klemens Budde, Marwan Mannaa, New England Journal of Medicine	2010	571
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions Adnan Sharif, Manfred Hecking, Aiko P. J. de Vries, American Journal of Transplantation	2014	509
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial Klemens Budde, Thomas Becker, Wolfgang Arns, The Lancet UrologyTransplantationKidney TransplantKidney ResearchDe-novo Kidney Transplants	2011	353

Page 1